SCHEMBL3823328

SCHEMBL3823328

CCOC(=O)c1nc(C)c(CCl)s1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
HPGD P15428 3/20 0.41
KDM4E B2RXH2 3/20 0.41
CYP1A2 P05177 2/20 0.41
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.39
CDC7 O00311 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 2/20 0.38
PDE4D Q08499 1/20 0.38
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
PKM P14618 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3823404 0.85 ALDH1A1 (0.45) ALDH1A1HPGDKDM4ECYP1A2GAA
SCHEMBL3821049 0.83 ALDH1A1 (0.44) ALDH1A1HPGDKDM4ECYP1A2GAA
SCHEMBL1503950 0.79 ALDH1A1 (0.45) ALDH1A1HPGDKDM4ECYP1A2GAA
SCHEMBL30037122 0.78 ALDH1A1 (0.40) ALDH1A1HPGDKDM4ECYP1A2GAA
SCHEMBL10206331 0.76 ALDH1A1 (0.36) ALDH1A1HPGDKDM4ECYP1A2GAA
SCHEMBL289991 0.76 ALDH1A1 (0.43) ALDH1A1HPGDKDM4ECYP1A2GAA
SCHEMBL3824920 0.75 ALDH1A1 (0.49) ALDH1A1HPGDKDM4ECYP1A2MAPT
SCHEMBL6114078 0.75 ALDH1A1 (0.53) ALDH1A1HPGDKDM4ECYP1A2GAA
SCHEMBL1560369 0.75 TRPM8 (0.42) ALDH1A1HPGDKDM4ECYP1A2GAA
SCHEMBL23291972 0.74 ALDH1A1 (0.47) ALDH1A1HPGDKDM4ECYP1A2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022251247-A1 MACROCYCLIC COMPOUNDS ZENO MANAGEMENT, INC. (US) 2022-12-01 WO disclosed
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 ALDH1A1 775/4885HPGD 675/4885KDM4E 1955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.